Eyeworld

90 | EYEWORLD | APRIL 2022 by Nathan Radcliffe, MD Glaucoma Editor As you read this issue of EyeWorld and prepare for the upcoming ASCRS Annual Meeting, we hope that you embrace glaucoma's declaration that complacency is not an option. I f there is one thing we have all learned as a result of the COVID-19 pandem- ic, it is that change finds us even when we don't want it. In the field of glaucoma, this is both a blessing and a curse. Glaucoma is an incurable disease, and patients still lose vision every day. Because of this, we welcome technological advancements, and we accept the challenge that we must advance our skill set on a nearly daily basis in order to stay up to date and provide the best care. The practi- cal downside of this is that change is coming at us from all directions in the field of glaucoma. We all had to entirely rearrange the way our of- fice flow and waiting rooms work because of the pandemic—but that isn't what I'm talking about. Other changes are coming to glaucoma as well. If you have been enjoying the adoption of new MIGS devices over the past decade, you are going to love the next year or two of glaucoma innovation. Our market is seeing the arrival of a number of new canaloplasty and goniotomy de- vices from many companies active in the MIGS space. To better prepare ourselves to handle a rare but difficult MIGS complication, we asked Daniel Lee, MD, and Sarah Van Tassel, MD, to discuss the management of cyclodialysis clefts. In the past few years, we have seen SLT become the preferred primary therapy for glau- coma in the U.K. as a result of the LiGHT study. Constance Okeke, MD, and Thomas Samuelson, MD, discuss SLT and our need for better adop- tion in this issue of EyeWorld. G UCOMA No change? No chance We have all seen virtual communication take a prominent role in education and other types of meetings over the pandemic. It only makes sense that virtual formats will ultimately take a more predominant role in education, and in this issue, Meenakshi Chaku, MD, and Anuradha Khanna, MD, talk about the adoption of a virtual training system for glaucoma surgi- cal education. As you read this issue of EyeWorld and prepare for the upcoming ASCRS Annual Meeting, we hope that you embrace glaucoma's declaration that complacency is not an option. EyeWorld and ASCRS are here to help us learn how to best care for our patients in an era of constant change.

• Cover